Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023

Published:2024-06 Issue: Volume:7 Page:100259
ISSN:2590-1567
Container-title:International Journal of Pharmaceutics: X
language:en
Short-container-title:International Journal of Pharmaceutics: X

Author:

Moseson Dana E.^ORCID,Tran Trong Bien^ORCID,Karunakaran Bharathi^ORCID,Ambardekar Rohan^ORCID,Hiew Tze Ning^ORCID

Publisher

Elsevier BV

Reference140 articles.

1. Impact of polymer type on thermal degradation of amorphous solid dispersions containing ritonavir;Alvarenga;Mol. Pharm.,2022

2. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm. Res.,1995

3. Amorphous solid dispersions: utilization and challenges in preclinical drug development within AstraZeneca;Anane-Adjei;Int. J. Pharm.,2022

4. Interplay of drug–polymer interactions and release performance for HPMCAS-based amorphous solid dispersions;Bapat;Mol. Pharm.,2024

5. Quality guidelines for oral drug candidates: dose, solubility and lipophilicity;Bayliss;Drug Discov. Today,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP